Flexion Therapeutics, Inc. Announces Appointment of Utpal Koppikar to Board of Directors
July 12, 2021 at 04:30 pm EDT
Flexion Therapeutics, Inc. announced the appointment of Utpal Koppikar, Chief Financial Officer of Atara Biotherapeutics, to its Board of Directors. Mr. Koppikar will serve as the chair of Flexion’s audit committee. Mr. Koppikar joined Atara Biotherapeutics in June 2018, and oversees Finance, Information Technology, and Investor Relations. Prior to his tenure with Atara, Mr. Koppikar held several senior financial leadership positions at Gilead Sciences.